ArticleJCI insight2025
Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth control.
Akhil Goud Pachimatla et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it